1. Trang chủ
  2. » Ngoại Ngữ

Percutaneous mitral valve repair with mitraclip (technique and outcomes

36 221 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 36
Dung lượng 2,19 MB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

Per Protocol Cohort 1st Surgery Re-operation MR > 2+... 2.5% p-value compares the distribution of MR grade in device with the distribution of MR grade in control at 12 months Fishers’ Ex

Trang 1

Percutaneous Mitral Valve Repair

with MitraClip:

Technique and Outcomes

Michael J Rinaldi, MD

Sanger Heart and Vascular Institute

Carolinas HealthCare System

Charlotte, NC

Trang 2

Disclosure Statement of Financial Interest

Consulting Fees/Honoraria Abbott Vascular

Trang 3

MitraClip MV Repair

• The only FDA approved percutaneous therapy for MR in the US

Trang 5

Anatomy and Etiology

– Papillary muscle dysfunction

• Fixed (LV dysfunction related posterior tethering)

• Transient (ischemia)

• Rheumatic changes

• Endocarditis

Trang 6

Degenerative MR

Trang 7

Functional MR

Trang 8

Continued Access: Surgical

Trang 9

EVEREST II Randomized Clinical Trial

Aug 2005 - Nov 2008 Randomized Cohort

N=279

Untreated

n=6 MitraClip n=15 Surgery

FMR N=48

DMR N=62

FMR N=18

(N=41)

DMR Surgery 77% Clinical F/U 5-Year Analysis

(N=48)

FMR Surgery 83% Clinical F/U 5-Year Analysis

(N=15)

Withdrew 24 Missing 2

Withdrew 6 Missing 1

Withdrew 12 Missing 2

Withdrew 3 Missing 0

Overall Distribution

74% DMR

26% FMR

Trang 10

Urgent CV Surgery Stroke

Trang 11

Per Protocol Cohort

1st Surgery Re-operation MR > 2+

Trang 12

2.5%

p-value compares the distribution of MR grade in device with the distribution of MR grade in control at 12 months

(Fishers’ Exact test)

Trang 13

NYHA Functional Class

Baseline vs 12 Months, Per Protocol, Matched Cases

0 20 40 60 80 100

87.9% NYHA Class I/II

I

II III

p-value compares the distribution of NYHA class at baseline to the distribution at 12 months within device and control

*p-value compares the distribution of NYHA class in device to the distribution in control at 12 months (Fishers’ Exact test)

Trang 14

Mitral Regurgitation Grade at 5 Years

Trang 15

Continued Access: Surgical

Trang 16

High Risk Cohort

Trang 17

High Risk Cohort

Trang 18

High Risk Cohort

NYHA Functional Class

18%

Trang 19

So Where Are We Now?

Ventricular element

Atrial element

Trang 20

Worldwide Experience Using

the MitraClip

*Data as of 8/31/2014 Source: Abbott Vascular

(High Risk Study)

Total

16,427

*As of 8/2014

Trang 21

Case Example

• 45yo M with a month of progressive SOB and abdominal pain

• AF with RVR, elevated LFTs, INR 2, Cr 1.7

• TTE severe MR due to P2 flail with EF 35% and RV failure

• Cath CI 1.5, wedge 30 with V 45, PA systolic

64, coronaries patent

• IABP placed and transferred

Trang 22

Sub-Acute MR with Shock

• Given severe RV failure and multi-organ

failure his operative mortality was felt to be too high for conventional surgery

• MitraClip for Sub-Acute MR with shock?

Trang 23

Sub-Acute MR with Shock

Trang 24

Transseptal Puncture

Bicaval View

SAX

Trang 25

Clip in LA – LVOT view

Trang 26

Clip into LV – LVOT view

Trang 27

Grasp Clip 1 – IC View

Trang 28

Lateral Jet after Clip 1 – IC view

Trang 29

Clip 2 lateral – IC view

Trang 30

Mild MR after 2 Clips – IC view

Trang 31

PV flow reversal now eliminated

Trang 32

Second Clip Release

Trang 33

Pre and Post Clip – 3D TEE

Trang 34

Favorable Outcome

Ngày đăng: 30/08/2015, 13:07

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

🧩 Sản phẩm bạn có thể quan tâm